aluates Reports

$ 0.0

Automative

Measles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-34D11827

Global Measles Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Measles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34D11827

Report

October 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Sanofi Pasteur

Merck

Novartis

China National Biotech Group

Bavarian Nordic

Emergent Biosolutions

MedImmune

Johnson & Johnson

CSL Limited

Serum Institute of India

Pfizer Inc

Measles Vaccine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Measles Vaccine - Market

The global market for Measles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Measles Vaccine by region & country, by Type, and by Application.

The Measles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles Vaccine.

Market Segmentation

Scope of Measles Vaccine - Market Report

Report Metric	Details
Report Name	Measles Vaccine - Market
CAGR	5%
Segment by Type:	Mumps Measles Rubella Vaccine, Live (MMR-II) Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Segment by Application	Children Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Measles Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Measles Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Measles Vaccine - Market report?

Ans: The main players in the Measles Vaccine - Market are GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited

What are the Application segmentation covered in the Measles Vaccine - Market report?

Ans: The Applications covered in the Measles Vaccine - Market report are Children, Adults

What are the Type segmentation covered in the Measles Vaccine - Market report?

Ans: The Types covered in the Measles Vaccine - Market report are Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

1 Market Overview

1.1 Measles Vaccine Product Introduction

1.2 Global Measles Vaccine Market Size Forecast

1.2.1 Global Measles Vaccine Sales Value (2019-2030)

1.2.2 Global Measles Vaccine Sales Volume (2019-2030)

1.2.3 Global Measles Vaccine Sales Price (2019-2030)

1.3 Measles Vaccine Market Trends & Drivers

1.3.1 Measles Vaccine Industry Trends

1.3.2 Measles Vaccine Market Drivers & Opportunity

1.3.3 Measles Vaccine Market Challenges

1.3.4 Measles Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Measles Vaccine Players Revenue Ranking (2023)

2.2 Global Measles Vaccine Revenue by Company (2019-2024)

2.3 Global Measles Vaccine Players Sales Volume Ranking (2023)

2.4 Global Measles Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Measles Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Measles Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Measles Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Measles Vaccine

2.9 Measles Vaccine Market Competitive Analysis

2.9.1 Measles Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Measles Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Mumps Measles Rubella Vaccine, Live (MMR-II)

3.1.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

3.2 Global Measles Vaccine Sales Value by Type

3.2.1 Global Measles Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Measles Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Measles Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Measles Vaccine Sales Volume by Type

3.3.1 Global Measles Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Measles Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Measles Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Measles Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Children

4.1.2 Adults

4.2 Global Measles Vaccine Sales Value by Application

4.2.1 Global Measles Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Measles Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Measles Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Measles Vaccine Sales Volume by Application

4.3.1 Global Measles Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Measles Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Measles Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Measles Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Measles Vaccine Sales Value by Region

5.1.1 Global Measles Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Measles Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Measles Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Measles Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Measles Vaccine Sales Volume by Region

5.2.1 Global Measles Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Measles Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Measles Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Measles Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Measles Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Measles Vaccine Sales Value, 2019-2030

5.4.2 North America Measles Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Measles Vaccine Sales Value, 2019-2030

5.5.2 Europe Measles Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Measles Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Measles Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Measles Vaccine Sales Value, 2019-2030

5.7.2 South America Measles Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Measles Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Measles Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Measles Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Measles Vaccine Sales Value

6.2.1 Key Countries/Regions Measles Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Measles Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Measles Vaccine Sales Value, 2019-2030

6.3.2 United States Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Measles Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Measles Vaccine Sales Value, 2019-2030

6.4.2 Europe Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Measles Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Measles Vaccine Sales Value, 2019-2030

6.5.2 China Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Measles Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Measles Vaccine Sales Value, 2019-2030

6.6.2 Japan Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Measles Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Measles Vaccine Sales Value, 2019-2030

6.7.2 South Korea Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Measles Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Measles Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Measles Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Measles Vaccine Sales Value, 2019-2030

6.9.2 India Measles Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Measles Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GSK

7.1.1 GSK Company Information

7.1.2 GSK Introduction and Business Overview

7.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GSK Measles Vaccine Product Offerings

7.1.5 GSK Recent Development

7.2 Sanofi-Pasteur

7.2.1 Sanofi-Pasteur Company Information

7.2.2 Sanofi-Pasteur Introduction and Business Overview

7.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi-Pasteur Measles Vaccine Product Offerings

7.2.5 Sanofi-Pasteur Recent Development

7.3 Merck

7.3.1 Merck Company Information

7.3.2 Merck Introduction and Business Overview

7.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Merck Measles Vaccine Product Offerings

7.3.5 Merck Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Introduction and Business Overview

7.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novartis Measles Vaccine Product Offerings

7.4.5 Novartis Recent Development

7.5 Pfizer

7.5.1 Pfizer Company Information

7.5.2 Pfizer Introduction and Business Overview

7.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Pfizer Measles Vaccine Product Offerings

7.5.5 Pfizer Recent Development

7.6 Serum Institute of India

7.6.1 Serum Institute of India Company Information

7.6.2 Serum Institute of India Introduction and Business Overview

7.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Serum Institute of India Measles Vaccine Product Offerings

7.6.5 Serum Institute of India Recent Development

7.7 China National Biotech Group

7.7.1 China National Biotech Group Company Information

7.7.2 China National Biotech Group Introduction and Business Overview

7.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 China National Biotech Group Measles Vaccine Product Offerings

7.7.5 China National Biotech Group Recent Development

7.8 Bavarian Nordic

7.8.1 Bavarian Nordic Company Information

7.8.2 Bavarian Nordic Introduction and Business Overview

7.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bavarian Nordic Measles Vaccine Product Offerings

7.8.5 Bavarian Nordic Recent Development

7.9 Emergent Biosolutions

7.9.1 Emergent Biosolutions Company Information

7.9.2 Emergent Biosolutions Introduction and Business Overview

7.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Emergent Biosolutions Measles Vaccine Product Offerings

7.9.5 Emergent Biosolutions Recent Development

7.10 Medimmune

7.10.1 Medimmune Company Information

7.10.2 Medimmune Introduction and Business Overview

7.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Medimmune Measles Vaccine Product Offerings

7.10.5 Medimmune Recent Development

7.11 Johnson & Johnson

7.11.1 Johnson & Johnson Company Information

7.11.2 Johnson & Johnson Introduction and Business Overview

7.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Johnson & Johnson Measles Vaccine Product Offerings

7.11.5 Johnson & Johnson Recent Development

7.12 CSL Limited

7.12.1 CSL Limited Company Information

7.12.2 CSL Limited Introduction and Business Overview

7.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 CSL Limited Measles Vaccine Product Offerings

7.12.5 CSL Limited Recent Development

8 Industry Chain Analysis

8.1 Measles Vaccine Industrial Chain

8.2 Measles Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Measles Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Measles Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Sanofi Pasteur

Merck

Novartis

China National Biotech Group

Bavarian Nordic

Emergent Biosolutions

MedImmune

Johnson & Johnson

CSL Limited

Serum Institute of India

Pfizer Inc

List of Tables

Table 1. Measles Vaccine Market Trends

Table 2. Measles Vaccine Market Drivers & Opportunity

Table 3. Measles Vaccine Market Challenges

Table 4. Measles Vaccine Market Restraints

Table 5. Global Measles Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Measles Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Measles Vaccine Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Measles Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Measles Vaccine Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Measles Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Measles Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Measles Vaccine

Table 13. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Measles Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Measles Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Measles Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Measles Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Measles Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Measles Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Measles Vaccine Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Measles Vaccine Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Measles Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Measles Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Measles Vaccine Price by Type (2019-2024) & (USD/MT)

Table 27. Global Measles Vaccine Price by Type (2025-2030) & (USD/MT)

Table 28. Global Measles Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Measles Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Measles Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Measles Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Measles Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Measles Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Measles Vaccine Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Measles Vaccine Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Measles Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Measles Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Measles Vaccine Price by Application (2019-2024) & (USD/MT)

Table 39. Global Measles Vaccine Price by Application (2025-2030) & (USD/MT)

Table 40. Global Measles Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Measles Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Measles Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Measles Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Measles Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Measles Vaccine Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Measles Vaccine Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Measles Vaccine Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Measles Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Measles Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Measles Vaccine Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Measles Vaccine Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Measles Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Measles Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Measles Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Measles Vaccine Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Measles Vaccine Sales Volume, (2025-2030) & (K MT)

Table 57. GSK Company Information

Table 58. GSK Introduction and Business Overview

Table 59. GSK Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. GSK Measles Vaccine Product Offerings

Table 61. GSK Recent Development

Table 62. Sanofi-Pasteur Company Information

Table 63. Sanofi-Pasteur Introduction and Business Overview

Table 64. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Sanofi-Pasteur Measles Vaccine Product Offerings

Table 66. Sanofi-Pasteur Recent Development

Table 67. Merck Company Information

Table 68. Merck Introduction and Business Overview

Table 69. Merck Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Merck Measles Vaccine Product Offerings

Table 71. Merck Recent Development

Table 72. Novartis Company Information

Table 73. Novartis Introduction and Business Overview

Table 74. Novartis Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Novartis Measles Vaccine Product Offerings

Table 76. Novartis Recent Development

Table 77. Pfizer Company Information

Table 78. Pfizer Introduction and Business Overview

Table 79. Pfizer Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. Pfizer Measles Vaccine Product Offerings

Table 81. Pfizer Recent Development

Table 82. Serum Institute of India Company Information

Table 83. Serum Institute of India Introduction and Business Overview

Table 84. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Serum Institute of India Measles Vaccine Product Offerings

Table 86. Serum Institute of India Recent Development

Table 87. China National Biotech Group Company Information

Table 88. China National Biotech Group Introduction and Business Overview

Table 89. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. China National Biotech Group Measles Vaccine Product Offerings

Table 91. China National Biotech Group Recent Development

Table 92. Bavarian Nordic Company Information

Table 93. Bavarian Nordic Introduction and Business Overview

Table 94. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 95. Bavarian Nordic Measles Vaccine Product Offerings

Table 96. Bavarian Nordic Recent Development

Table 97. Emergent Biosolutions Company Information

Table 98. Emergent Biosolutions Introduction and Business Overview

Table 99. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 100. Emergent Biosolutions Measles Vaccine Product Offerings

Table 101. Emergent Biosolutions Recent Development

Table 102. Medimmune Company Information

Table 103. Medimmune Introduction and Business Overview

Table 104. Medimmune Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 105. Medimmune Measles Vaccine Product Offerings

Table 106. Medimmune Recent Development

Table 107. Johnson & Johnson Company Information

Table 108. Johnson & Johnson Introduction and Business Overview

Table 109. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 110. Johnson & Johnson Measles Vaccine Product Offerings

Table 111. Johnson & Johnson Recent Development

Table 112. CSL Limited Company Information

Table 113. CSL Limited Introduction and Business Overview

Table 114. CSL Limited Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 115. CSL Limited Measles Vaccine Product Offerings

Table 116. CSL Limited Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Measles Vaccine Downstream Customers

Table 120. Measles Vaccine Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Measles Vaccine Product Picture

Figure 2. Global Measles Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Measles Vaccine Sales Volume (2019-2030) & (K MT)

Figure 5. Global Measles Vaccine Sales Price (2019-2030) & (USD/MT)

Figure 6. Measles Vaccine Report Years Considered

Figure 7. Global Measles Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Measles Vaccine Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles Vaccine Revenue in 2023

Figure 10. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Mumps Measles Rubella Vaccine, Live (MMR-II) Picture

Figure 12. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Picture

Figure 13. Global Measles Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Measles Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Measles Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 16. Global Measles Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Measles Vaccine Price by Type (2019-2030) & (USD/MT)

Figure 18. Product Picture of Children

Figure 19. Product Picture of Adults

Figure 20. Global Measles Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Measles Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Measles Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 23. Global Measles Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Measles Vaccine Price by Application (2019-2030) & (USD/MT)

Figure 25. North America Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Measles Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Measles Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Measles Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Measles Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Measles Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Measles Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Measles Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Measles Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Measles Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Measles Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Measles Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Measles Vaccine Industrial Chain

Figure 59. Measles Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions